| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/16/2009 | EP2099804A1 Compounds for the treatment of hepatitis c |
| 09/16/2009 | EP2099789A1 Inhibitors of hiv replication |
| 09/16/2009 | EP2099778A2 Amido anti-viral compounds |
| 09/16/2009 | EP2099762A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099761A2 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099760A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099759A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099758A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099494A2 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 09/16/2009 | EP2099483A1 Immunization protocol against the 4 dengue serotypes |
| 09/16/2009 | EP2099482A2 Chlamydia pneumoniae vaccine and methods for administering such a vaccine |
| 09/16/2009 | EP2099479A2 Salmonella vaccine in poultry |
| 09/16/2009 | EP2099466A1 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears |
| 09/16/2009 | EP2099441A1 Metal delivery agents and therapeutic uses of the same |
| 09/16/2009 | EP2099299A2 Oxazolidinone derivatives and methods of use |
| 09/16/2009 | EP1987025B1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 09/16/2009 | EP1924593B1 Hcv ns3 protease inhibitors |
| 09/16/2009 | EP1638599B1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 09/16/2009 | EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 09/16/2009 | EP1542732B1 Fusion proteins of mycobacterium tuberculosis |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1486500B1 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacteria |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1478364B1 Selective antibacterial agents |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1349568B1 Immunomodulatory constructs and their uses |
| 09/16/2009 | EP1343814B1 Immunogenic glycopeptides, screening, preparation and uses |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | EP1223978B9 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 09/16/2009 | EP0941087B1 Topical formulations containing as a therapeutic active agent a monoglyceride for treating of mucosa infections |
| 09/16/2009 | CN101532030A Recombinant influenza virus vector carrying foreign genes in NA segment and preparation method and application thereof |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531707A New antitumoral compounds |
| 09/16/2009 | CN101531691A Triazole glucoside, method for synthesizing same by enzyme chemical method and application thereof |
| 09/16/2009 | CN101531680A Method for synthesizing (R)-9(2-(diethyl phosphonyl methoxyl) propyl)-adenine |
| 09/16/2009 | CN101531679A Method for preparing phosphonyl methoxyl nucleotide analogue |
| 09/16/2009 | CN101531656A Lamivudine crystal form and preparation method thereof |
| 09/16/2009 | CN101531637A A novel compound capable of restraining and blocking M2 ion channel activity and application thereof |
| 09/16/2009 | CN101531630A Asymmetric chiral double-Schiff base simple synthesizing method |
| 09/16/2009 | CN101531590A Ginkgoic acid preparation method using macroporous adsorption resin |
| 09/16/2009 | CN101531579A Diaromatic compound with bioactivity |
| 09/16/2009 | CN101531578A Method for preparing axial chirality diaromatic compound with optical activity |
| 09/16/2009 | CN101530620A Triphosadenine intercalated houghite membrane and preparation method thereof |
| 09/16/2009 | CN101530615A Divalent recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530614A Pentavalent recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530613A Infectious spleen and kidney necrosis virus vaccine and preparation method and application thereof |
| 09/16/2009 | CN101530612A Type-16 recombinant human papilla virus vaccine |
| 09/16/2009 | CN101530602A Traditional Chinese medicine for treating swine fever |
| 09/16/2009 | CN101530546A Chinese medicament for preventing hand-foot-and mouth disease |
| 09/16/2009 | CN101530529A Traditional Chinese medicine for treating plague |
| 09/16/2009 | CN101530525A Medicament for treating chicken bacillus coli |
| 09/16/2009 | CN101530514A A salve for treating zoster |
| 09/16/2009 | CN101530483A Preparation method of tropaeolum oral liquid |
| 09/16/2009 | CN101530481A Pigeon pox resisting Chinese medicinal composition and method for preparing oral liquid thereof |
| 09/16/2009 | CN101530475A Application of pink plumepoppy herb extract in veterinary drugs of economic animals |
| 09/16/2009 | CN101530474A Compound qinlan oral liquid |
| 09/16/2009 | CN101530466A Nano medicament containing oregano oil and vitamins |
| 09/16/2009 | CN101530465A Total salvianolic acid and Panax notoginsenosides and application of mixture thereof in treatment of septicemia |
| 09/16/2009 | CN101530449A Method of preparing honeysuckle extract by applying membrane filtration technology |
| 09/16/2009 | CN101530444A Soft capsules of volatile oil of chrysanthemum |
| 09/16/2009 | CN101530436A Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 09/16/2009 | CN101530434A Method for preparing silkworm powder, pupa powder or pupa serum powder containing antibacterial peptide and application of same |
| 09/16/2009 | CN101530431A Method for preparing biological agent for treating wet beriberi |
| 09/16/2009 | CN101530416A Composition containing adefovir dipivoxil, and preparation method thereof |
| 09/16/2009 | CN101530405A Citric acid and compound citric acid application in pharmacy |
| 09/16/2009 | CN101530395A Method for preparing LTB-carboxymethyl chitosan influenza vaccine intranasal immunization microspheres |
| 09/16/2009 | CN101530393A Clindamycin phosphate lipidosome freeze-dried preparation and preparation method thereof |
| 09/16/2009 | CN101530112A An air sterilization freshener, a preparation method and a using method thereof |
| 09/16/2009 | CN100540548C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 09/16/2009 | CN100540051C Modified vaccinia virus ankara for the vaccination of neonates |
| 09/16/2009 | CN100540039C Compound wild chrysanthemum flower skin bacteria inhibitor and preparation method thereof |
| 09/16/2009 | CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 09/15/2009 | US7589207 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 09/15/2009 | US7589204 Indane compounds as CCR5 antagonists |
| 09/15/2009 | US7589099 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor; |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7589077 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus |
| 09/15/2009 | US7589075 e.g., an N6-benzyladenosine-5'-uronamide |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7589056 Agent for the prevention and treatment of sexually transmitted diseases-I |
| 09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | US7588753 Synergistically pro-penetrating solutions for ungual/peri-ungual dermatological/cosmetic applications |
| 09/15/2009 | US7588752 Derived from milk protein casein; for use in dentistry |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2438663C Cyclic peptide |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2407754C Prodrugs of hiv replication inhibiting pyrimidines |
| 09/15/2009 | CA2406562C Hiv replication inhibiting pyrimidines and triazines |
| 09/15/2009 | CA2402390C Process for the preparation of pyrimidone derivatives with antifungal activity |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2270423C Prophylactic/therapeutic agent |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/14/2009 | CA2640954A1 Hepatitis c virus inhibitors |
| 09/11/2009 | WO2009111739A2 Treatment of herpes virus related diseases |
| 09/11/2009 | WO2009111653A2 Antiviral therapeutic agents |
| 09/11/2009 | WO2009111607A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity |